You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade-thalidomide-dexamethasone

Showing 1 - 25 of 2,762
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
Has Results
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Renal Failure
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 13, 2022

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

Multiple Myeloma Trial in Worldwide (Velcade (Bortezomib), Thalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Velcade (Bortezomib)
  • +2 more
  • Graz, Austria
  • +80 more
Sep 21, 2021

Multiple Myeloma Trial in Little Rock (M-VTD-PACE, TT3-LITE Regimen (L-TT3))

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences, Myeloma Institute f
Oct 4, 2021

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 7, 2021

Daratumumab in Combination With Bortezomib, Thalidomide, and

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
  • (no location specified)
Sep 27, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 10, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bortezomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 4, 2022

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Mar 3, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Multiple Myeloma Trial in Singapore (Bortezomib, Cyclophosphamide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Singapore, Singapore
    National University Hospital
Jan 23, 2020

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, velcade, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +12 more
Aug 25, 2021

Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Neurotoxicity
  • Duarte, California
    City of Hope Medical Center
Aug 17, 2021

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Multiple Myeloma Trial in Torino (Bortezomib, Melphalan, Prednisone, Thalidomide, Bortezomib, Melphalan, Prednisone)

Completed
  • Multiple Myeloma
  • Bortezomib, Melphalan, Prednisone, Thalidomide
  • Bortezomib, Melphalan, Prednisone
  • Torino, Italy
    A.O.U. S. Giovanni Battista
Dec 22, 2020

Langerhans Cell Histiocytosis Trial in Beijing (thalidomide combined with dexamethasone and cyclophosphamide)

Recruiting
  • Langerhans Cell Histiocytosis
  • thalidomide combined with dexamethasone and cyclophosphamide
  • Beijing, China
    Peking Union Medical College Hospital
Jun 7, 2021

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma Trial in New York (thalomid, lenalidomide, clarithromycin)

Completed
Has Results
  • Multiple Myeloma
  • New York, New York
    Weill Medical College of Cornell University
Apr 30, 2021